BACKGROUND: Near-infrared spectroscopy (NIRS) non-invasively monitors muscle tissue oxygen saturation (StO 2 ). It may provide a continuous noninvasive measurement to identify occult hypoperfusion, guide resuscitation, and predict the development of multiple organ dysfunction (MOD) after severe trauma. We evaluated the correlation between initial StO 2 and the development of MOD in multi-trauma patients.
INTRODUCTION
Traditional methods for identifying shock states are notoriously insensitive and remain problematic in acute resuscitation of traumatic patients. For example, systemic hypotension is considered a late sign of shock and a poor indicator of systemic hypoperfusion. [1] [2] [3] [4] [5] [6] The information gathered from tests of serum lactate and base defi cit, even delayed bedside test, can be altered by numerous chronic illness states and regional perfusion abnormalities, or normalized early in shock states. [7] Invasive monitoring of central venous pressure (CVP) and central venous oxygen saturation (SvO 2 ), which is common in intensive care unit (ICU), may not adequately reflect early shock states or influence outcomes beyond directed resuscitation. [8] [9] [10] As there is no individual definitive gold standard for the early diagnosis of shock and multiple organ dysfunction, these surrogates frequently serve this purpose in combination.
An ideal monitoring would rapidly, noninvasively and continuously reflect the states of tissue perfusion in a patient, i.e. initial and ongoing assessment of shock, response to therapy and prediction of multiple organ dysfunction (MOD). Near-infrared spectroscope (NIRS), a non-invasive monitor of muscle tissue oxygen saturation (StO 2 ) using infrared light absorption, has been studied in many traumatic and surgical patients. Recent studies [11] [12] [13] [14] [15] [16] have asserted that StO 2 normalization is associated with improved outcomes during resuscitation of patients in hemorrhagic shock. In this study, we prospectively assessed the monitoring of StO 2 in the resuscitation period to predict the development of MOD, further validating previous studies in a large sample of trauma patients. [19, 20] We also analyzed the association of StO 2 measurements with lactate and shock indexes of the predefi ned trauma patients.
METHODS

Study design
This prospective, observational, nonrandomized cohort study was conducted at a Level I trauma center with an annual emergency department (ED) volume of 92 000 patients and an average of over 900 trauma alert patients per year. The study went through a 15 month period between April 2005 and July 2006.
Inclusion criteria
Included were adult patients aged 18 years or over who arrived at the emergency department within 3 hours of traumatic injury and met the standardized trauma team activation criteria (Table 1) . Figure 1 shows a complete list of exclusion criteria. Excluded patients included those known to be pregnant, those with known "Do Not Resuscitate" order, and those requiring isolation of both hands for forensic gunshot residue testing. In addition, patients with bilateral upper extremity fractures or absence of adequate Experimental device NIRS-derived StO 2 was measured using the T.Ox™ Tissue Oximeter (ViOptix Inc, Fremont, Ca) which was applied to each patient through a small adhesive sensor attached to the thenar eminence of an uninjured upper extremity.
Exclusion criteria
Protocol
The StO 2 monitor was placed upon the arrival of trauma patients to the ED/Trauma Center. The study protocol was reviewed and approved by the institutional review board (IRB). Because of the minimal risk of the non-invasive monitoring device and the critical nature of trauma resuscitations, permission was granted by the IRB to routinely place the noninvasive NIRS monitoring device upon the arrival of all trauma alert patients. Informed consent to participate in the study and allow record abstraction was obtained from all participants during their ED or hospital stay.
StO 2 values were automatically recorded by the NIRS device. The lowest value during the initial 5 minutes of sampling was used as the initial value, and hourly timeaveraged values were used thereafter. The device remained in place on all patients admitted to the trauma ICU for 24 hours. For those patients admitted to a non-ICU bed, discharged, or deceased, the monitor was removed after completion of the ED care course. StO 2 values were not made available to the clinical team during patient care, and therefore had no impact on the usual care provided.
Data collected by the research staff included demographic information, date, time, mechanism/ cause, referral hospital information, prehospital interventions including vital signs, intravenous fluids (IVF) and procedures, and initial assessment on ED arrival. Our standardized trauma protocol includes performance of vital signs at least every 10 minutes for the first 60 minutes of resuscitation and the following standardized trauma labs: complete blood count (CBC), comprehensive metabolic profile (CMP), coagulation profile with international normalized ratio (INR), serum lactate, arterial blood gas (ABG), and urine drug screening (UDS). All intravenous fluids and blood products administered were recorded.
Repeat labs were obtained from patients admitted There are a number of scoring systems that have been used to describe organ dysfunction and failure in critically ill and injured patients. The Marshall Score or multiple organ dysfunction (MOD) score has been extensively used in injured patients (Table 2) . [10, 19, [21] [22] [23] [24] [25] [26] [27] Given that initial MOD calculations would reflect the traumatic injury and not subsequently prolong organ dysfunction, MOD occurred 72 hours later. The MOD score was not summation score, but rather daily score obtained up to 7 days of hospitalization, a duration commonly used in the recent literature to account for prolonged organ dysfunction after trauma. A P value less than 0.05 was considered statistically signifi cant for all tests.
Analysis
This study was designed to determine the statistical significance (P<0.05) of StO 2 for MOD based on the incidence of 14%-42% (MOD score 6 or greater excluding GCS) in high-risk trauma patients with multiple organ failure. [17] Calculations of the error rate and power required that 26 MOD patients be enrolled in the study. The patients were grouped by the presence or absence of MOD, and initial serum lactate values were classifi ed into no shock (lactate <2 mmol/L), mild shock (lactate 2-4 mmol/L), and moderate/severe shock (lactate >4 mmol/L) groups. [28, 29] Shock index, the ratio of pulse to systolic blood pressure, was categorized as normal (<1.0) or abnormal (≥1.0). [30, 31] Multivariate regression and rank-sum comparison were used to compare the groups (InStat v 3.0, GraphPad Software, La Jolla, CA, USA). Regression analyses were done initially with NIRS values as the dependent 
RESULTS
In the period of study, 841 adults had trauma activations. Of these patients, 229 had the NIRS device placed during trauma activations from which 78 patients completed the enrollment process (Figure 1 ). Their mean age was 40.9 years (SD 18.2) and 84.6% of the patients were male. Of these patients, 79% had a blunt trauma. The mean injury severity score (ISS) of all the patients was 18.3 (SD 9.9).
Twenty-six of the 78 (33.3%) patients developed MOD after the first 72 hours ( Table 3 ). The mean ISS in MOD patients was 29.9 (SD 11.5), which was signifi cantly higher than that in non-MOD patients, 12.1 (SD 9.1; P<0.0001). The mean initial StO 2 value (53.3; SD 10.3) was significantly lower in the MOD patients than in the non-MOD patients (61.1; SD 10.0) (P=0.002). The mean shock index (SI) in the MOD patients was 0.92 (SD 0.28), which was also signifi cantly higher than that in the non-MOD patients (0.73; SD 0.19) (P=0.0007). Lactate values were not significantly different between the two groups (P=0.168).
Comparison of the inclusion and exclusion populations demonstrated that the study had a representative sample of your trauma population (Table 4) . Male patients in the excluded population were less than 81% compared to 85%, but this was not statistically significant. Also, ISS, shock index and lactates were slightly higher in the excluded group but this observation was not statistically signifi cant. There was no signifi cant difference in mode of arrival or level of trauma activation.
NIRS values discriminated between those with moderate-severe shock (lactates>4 mmol/L, n=21) on arrival and those without shock (lactate<2, n=34) with mean StO 2 values of 51.4 (SD 11.2) vs. 65.8 (SD 7.2), respectively (P<0.001). NIRS was unable to discriminate those with mild shock defined by mid-range (2.0-4.0 mmol/L) lactates (P>0.05). However, NIRS was able to distinguish those with an abnormal shock index (≥1.0) from those with a normal SI (<1.0), with mean StO 2 values of 48.1 (SD 10.9) vs. 60.2 (SD 9.2), respectively (P<0.0001) ( Table 5 ).
DISCUSSION
The traditional methods for identifying and monitoring shock vary, and it is accepted that monitoring a patient's response to ongoing resuscitation efforts, or lack thereof, is essential. Patients may remain inadequately or be under-resuscitated despite normalizing blood pressure measurements, leading to persistent hypoperfusion and tissue ischemia with the development of multiple organ dysfunction (MOD) syndrome and the resultant increase of morbidity and mortality. [10] StO 2 values were evaluated as a marker of resuscitation and a method of identifying a cohort of patients potentially at risk for developing multiple organ dysfunction or being predictive of death. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In most circumstances, the values were not initiated at the immediate point of care in the ED but within 60 minutes after arrival. In this study, the patient population included all patients that met the established trauma criteria (Table 1) , and monitoring began at the point of arrival at the ED which allows for better data correlation in the acute resuscitation period and potentially great decrease of predictive capabilities.
The StO 2 minimum value during the first 60 minutes of resuscitation has been used as the predictive measurement for subsequent adverse effects. [17] [18] [19] [20] Also, as the different devices used for StO 2 assessment can obtain varied samples over time, a time-average value for trend assessments is frequently predefi ned for each study.
Since initial MOD calculations would refl ect traumatic injury and not subsequent prolonged organ dysfunction, MOD was calculated after the initial 72 hours. [24] [25] [26] [27] We also modified the MOD score to exclude GCS because of the bias of possible underlying brain injury in trauma. The MOD score was not summation scoring, but rather daily scores obtained up to 7 days of hospitalization. This approach remains consistent with previous analyses showing the delayed effects of multi-organ failure due to trauma. [28] Impaired cellular oxygen utilization has been recognized as potential evidence for the development of multiple organ dysfunction. [9] Additional small studies [13, 14] have identifi ed StO 2 values of skeletal muscle as a consistent measurable indicator of resuscitation status. Further studies [19, 20] identifi ed the thenar eminence as a more reproducible location for tissue oximetry measurement regardless of the StO 2 device utilized. In addition, values have been established for determination of severe shock from non-severe shock state. [19, 20, 27] However, data acquisition and the associated trend values are far more predictive of persistent shock state, but may be more predictive of the development of MOD. [29] [30] [31] Cohn et al [19] found that StO 2 was useful in discriminating patients who would later develop MOD after major trauma from those who would not. As the study differred in the onset time and duration of monitoring, the underlying data were supportive of the same results. Similarly, a pre-hospital model identified the decreasing tissue oximetry levels associated with in-hospital life-saving interventions. [32] 
LIMITATIONS
This observational study has several limitations. As a pilot study of feasibility regarding immediate NIRS device placement under a pre-existent standardized trauma protocol, the study was not able to explicitly predict those who will develop MOD. In addition, the study was limited by the number of devices available for the enrollment process, and convenient sampling was based on the availability of NIRS monitors and study staff. However, the enrollment did have a representative sample of the entire trauma population. Numerous patients were excluded from the study because of powering down of the device and absence of continuous StO 2 measurements during the period of resuscitation. Possibly, the second limitation was due to the small number of enrolled patients and those with MOD. Moreover, there was enrollment bias induced by clinicians who were familiar with the device and the study. We also did not investigate the trends in StO 2 measurements over time and their relationship to events occurring in the ICU setting, but the lowest values in the initial resuscitation and subsequent patient outcomes. In addition, this study was not able to detect StO 2 differences between mild-and moderate-severe shock.
In conclusion, we found that non-invasive, continuous StO 2 near-infrared spectroscopy values during initial trauma resuscitation correlate with subsequent development of multiple organ failure and also with shock index in the acute resuscitation of multi-trauma patients. NIRS can also discriminate between those with no and moderate-severe shock as determined by intermittent invasive serum lactate test.
As a continuous non-invasive measure of hypoperfusion, we believe that StO 2 values may provide further objective data to overcome the existing limitations of traditional assessments of hypoperfusion and shock. In addition, as an early indicator of hypoperfusion, StO 2 measurement may assist with not only dynamic resuscitation guidance, but with early identifi cation of post-resuscitation decline with the potential to assuage recurrent hypoperfusion in all modalities of shock.
Further studies are warranted to ascertain the validity of these findings, with an emphasis on non-invasive predictive modeling, impact of early intervention from trending data, and outcome measures including the length of ICU stay, morbidity/mortality, and cost savings. Expansion into the pre-hospital setting, especially for regions with extended transport durations for trauma patients, may prove useful in guiding outcome-based resuscitation protocols within trauma systems.
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